Locations:

In Open AAA Repair, Acute Normovolemic Hemodilution Offers Advantages Over Standard Transfusions

Technique reduces blood requirements and helps normalize coagulation levels

21-HVI-2255659_blood-transfusion_650x450

Acute normovolemic hemodilution (ANH) in patients undergoing open abdominal aortic aneurysm (AAA) repair appears to reduce intra- and postoperative blood transfusion requirements, help normalize coagulation parameters and decrease hospital stay.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

According to a retrospective review of Cleveland Clinic patients published in the Journal of Vascular Surgery, ANH — a blood conservation technique that involves controlled collection and storage of patients’ whole blood shortly after induction of anesthesia — may be an improvement over standard transfusion practices for open surgical management of AAA. The technique is accompanied by intravenous infusions of crystalloids or colloids to maintain intravascular volume.

“Although acute normovolemic hemodilution has been well studied in cardiac surgery and neurosurgery, and briefly studied in a mixed cohort of vascular surgery populations, data on the technique’s utility specifically in open AAA repair are limited,” says study co-author Jarrad Rowse, MD, of Cleveland Clinic’s Department of Vascular Surgery. He notes that this study appears to be the first to evaluate the effect of ANH on use of intra- and postoperative fluids, blood components and colloids as well as its effect on coagulation function in the AAA population.

“The development of techniques designed to reduce blood loss in surgical patients continues to be a high priority, as the long-term sequelae of allogeneic blood transfusion are an ongoing source of clinical concern,” adds study co-author Jia Lin, MD, PhD, a cardiothoracic anesthesiologist at Cleveland Clinic. “However, new research shows that fewer red cells and other critical elements are lost when acute normovolemic hemodilution is employed — a benefit that can help patients maintain acceptable hematocrit levels and obviate the need for further intervention in patients undergoing open AAA repair.”

Advertisement

Study essentials

The study reviewed all 209 patients who underwent elective open AAA repair at Cleveland Clinic from 2017 to 2019. Among these, the researchers identified those who were eligible for ANH and had a hematocrit > 38%, normal ventricular function, a normal coagulation profile, and absence of cardiac ischemia, valvular disease and late-stage chronic kidney disease. Of the 76 patients who met these inclusion criteria, 27 were managed with ANH and 49 with standard transfusion practices.

Comparison of the ANH and standard transfusion groups revealed the following:

  • Allogenic packed red blood cell (PRBC) transfusion requirements were lower in the ANH group intraoperatively (P = 0.02), at 24 and 48 hours postoperatively (P = 0.008 and P = 0.007, respectively) and throughout the hospital stay (P = 0.011).
  • There were no between-group differences in intraoperative platelet or cryoprecipitate transfusions.
  • At 48 hours, ANH was associated with significantly higher platelet counts relative to standard transfusion, as well as with lower partial thromboplastin time and lower international normalized ratio (INR).
  • There were no significant differences between the groups in rates of myocardial infarction, death, return to the operating room or other clinical outcomes.
  • Hospital length of stay was shorter in the ANH group (7.0 ± 2.7 vs. 8.8 ± 4.8 days; P = 0.041).

Promising, but prospective confirmation needed

“These retrospective data show that acute normovolemic hemodilution in the setting of open AAA repair reduced intra- and postoperative transfusion requirements while improving platelet counts and INRs at 48 hours and shortening patients’ length of stay,” observes Dr. Rowse. “The fact that patients undergoing this technique showed improved postoperative coagulation parameters and significantly shorter length of stay is encouraging, as both of these are known to improve clinical outcomes.”

Advertisement

The authors write that these findings can help inform the design of a prospective randomized trial and that a multivariate analysis may provide further insights as more Cleveland Clinic patients undergo ANH. Ultimately, they note, a larger prospective investigation is needed to fully confirm the promise of ANH as a favorable blood conservation strategy for patients undergoing open AAA repair.

Advertisement

Related Articles

Black-and-white scan with red and blue highlights

Revising Carotid Duplex Criteria Helped Identify More Treatable Asymptomatic Stenosis

Lower threshold expanded revascularization candidacy without raising early complication rates

human intestines with inset showing gut microbes

TMAO Emerges as a Biomarker for AAA Risk

Elevated levels of the gut microbial metabolite predict prevalence and adverse outcomes in community-based study

physician pointing to a heart model and speaking to a woman

Cardiovascular Implications of Clonal Hematopoiesis of Indeterminate Potential (CHIP)

They generally depend on the mutated gene, clone size and clinical setting

cardiac echo and cardiac CT images side by side

Indexed CTA Measures Sharpen Risk Prediction in Ascending Aortopathy

Large analysis adds to evidence that absolute diameter alone may miss vulnerable patients

operating room during robotic lung transplant surgery

Successful First Case Launches Cleveland Clinic’s Robotic Lung Transplant Program

Procedure places the center among only a handful worldwide to offer the minimally invasive approach

stylized illustration of cholesterol particle floating in bloodstream

Novel siRNA Produces Deep, Durable Reduction in Lp(a)

Phase 1 trial shows up to 97% decrease through 48 weeks with good tolerability

converging lines on a graph pointing downward

Oxidized Phospholipids Track Closely With Lp(a) Reductions in Clinical Trial

Post hoc ALPACA analysis boosts biological rationale for ongoing outcomes trial of lepodisiran

sight picture overlaid on DNA double helix

Positive Effects of CRISPR-Cas9 Gene Editing for Dyslipidemia Endure Through 1 Year

Durability findings propel potential one-time treatment approach to phase 1b testing

Ad